David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer

David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT Southwestern Medical Center, shared a post on X about a recent paper by Ann H.Klopp et al., commenting:

“More on the results of NRG Oncology, The GOG Foundation Inc. 238, Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer. Now in print in Journal of Clinical Oncology. From International Journal of Gynaecological Cancer.”

“Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial”

Journal: ASCO Publications.

Authors: Ann H. Klopp, Danielle Enserro, Matthew Powell, Marcus Randall, Julian C. Schink, Robert S. Mannel, Laura Holman, David Bender, Christina L. Kushnir, Floor Backes, Susan L. Zweizig, Steven Waggoner, Kristin A. Bradley, Lana DeSouza Lawrence, Parviz Hanjani,Christopher J. Darus, William Small Jr., Higinia R. Cardenes, Jonathan M. Feddock, David S. Miller.

Additional information
Source: David Scott Miller/X